Drug intelligence / Profile preview

Zicam Allergy Relief

Development stage
Unknown
Lead developer
Matrixx Initiatives
Administration
Intranasal
01

Overview

Zicam Allergy Relief is a homeopathic, over-the-counter (OTC) intranasal spray formulated for the temporary relief of symptoms associated with allergic rhinitis and hay fever, including sneezing, runny nose, itchy and watery eyes, and nasal congestion. The product was originally developed by Matrixx Initiatives and is currently marketed by Church & Dwight. It contains a combination of four active ingredients in highly diluted homeopathic preparations: *Galphimia glauca*, *Histaminum hydrochloricum* (histamine dihydrochloride), *Luffa operculata*, and *Sulphur*. As a homeopathic remedy, it is designed to be non-drowsy and non-habit-forming, operating on the principle of 'like cures like.' However, it has not been evaluated by the FDA for safety or efficacy, and the agency has noted a lack of scientific evidence supporting the effectiveness of homeopathic treatments.

Brand names
Zicam Allergy Relief
Other names
galphimia glauca + histaminum hydrochloricum + luffa operculata + sulphur
02

Targets

HRH1 (Histamine H1 Receptor)HRH2 (Histamine H2 Receptor)HRH3 (Histamine Receptor H3)HRH4 (Histamine H4 receptor)

Beyond the preview

Go deeper on Zicam Allergy Relief.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zicam Allergy Relief.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call